Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,602.02
    -1,615.94 (-3.22%)
     
  • CMC Crypto 200

    1,264.96
    -93.05 (-6.85%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

GLOBAL BIOMATERIALS MARKET FORECAST 2021-2028

KEY FINDINGS The global biomaterials market is projected to develop with a CAGR of 13. 45% over the projected years of 2021 to 2028. The market growth is attributable to key factors such as the use of biomaterials in plastic surgeries as well as bone fixation, inventions in the field of biomaterials, government support for research and development initiatives, applications of biomaterials in wound healing therapies, and the high incidence of cardiovascular diseases and geriatric population.

New York, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL BIOMATERIALS MARKET FORECAST 2021-2028" - https://www.reportlinker.com/p06185886/?utm_source=GNW


MARKET INSIGHTS
Biomaterials are characterized as substances engineered to become biocompatible for their interaction with biological systems.Biomaterials can be categorized as synthetic and natural.

Synthetic materials comprise metals, ceramics, and polymers, whereas natural biomaterials are derived from natural sources, including animal tissues, or are engineered in laboratories.
Biomaterials are increasingly found in bioimplant devices, assisting in the treatment of bone fixation and plastic surgeries globally.These materials facilitate fabrication and flexibility and are biocompatible.

Moreover, their range of mechanical, chemical, electrical, and thermal behaviors widen when integrated with different materials as composites.As per the Australian National Joint Replacement Registry, the total number of joint replacement procedures performed in Australia was 1,492,892 at the end of 2018.

Moreover, in the same year, knee replacements rose by 1.2%, with the revision burden equating to 8.7%.

REGIONAL INSIGHTS
The global biomaterials market growth evaluation constitutes the assessment of Asia-Pacific, North America, Europe, and Rest of World.The Asia-Pacific is anticipated to grow with the highest CAGR over the forecasted years.

The regional market’s growth is primarily credited to the steady population growth and the increasing urbanization. Moreover, effective government policies combined with financial support in research and development across emerging economies like India and South Korea play a vital role, as well.

COMPETITIVE INSIGHTS
The intensity of industrial rivalry entails the extent to which manufacturers within the global biomaterials market can increase the pressure to gain a competitive advantage across international and regional markets. As a result, the competition in the global biomaterials market is expected to remain high during the forecast period.
The top firms operating in the market are Royal DSM, Zimmer Biomet, BASF SE, Evonik Industries, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. BASF
2. BBS-BIOACTIVE BONE SUBSTITUTES
3. BIORETEC LTD
4. CARPENTER TECHNOLOGY CORPORATION
5. CELANESE CORPORATION
6. COLLAGEN SOLUTIONS PLC
7. CORBION NV
8. COVESTRO AG
9. DENTSPLY SIRONA
10. EVONIK INDUSTRIES
11. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
12. NOBLE BIOMATERIALS INC
13. ROYAL DSM
14. VICTREX PLC
15. WRIGHT MEDICAL GROUP NV
16. ZIMMER BIOMET HOLDINGS INC
Read the full report: https://www.reportlinker.com/p06185886/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001